Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.

Takashi NagaiTaku NaikiKeitaro IidaSatoshi NozakiToshiki EtaniYosuke SugiyamaRyosuke AndoTakahiro YanaseRyosuke ChayaYoshinobu MoritokiDaichi KobayashiHidetoshi AkitaTakehiko OkamuraTakahiro Yasui

Published in: Asian Pacific journal of cancer prevention : APJCP (2019)

Higher values of SMI inclination, indicating a faster rate of skeletal muscle mass reduction, may serve as a useful predictive marker for OS in mUC patients undergoing second-line GD chemotherapy.

Keyphrases

skeletal muscle
patients undergoing
locally advanced
insulin resistance
blood flow
chemotherapy induced
type diabetes
radiation therapy
adipose tissue